QCM
IDXX icon

Qsemble Capital Management’s Idexx Laboratories IDXX Stock Holding History

Qsemble Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$829K Buy
+1,574
New +$883K 0.11% 243
2023
Q2 		– Sell
-500
Closed -$250K – 268
2023
Q1 		$250K Buy
+500
New +$239K 0.17% 194

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Qsemble Capital Management's IDXX Position: Q2 2026 in Review

Qsemble Capital Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 1,574 shares worth $829K. The stake represents 0.11% of the portfolio and ranks #243 among its holdings. This is a return to the name: Qsemble Capital Management previously reported a position in IDXX as recently as Q1 2023.

Qsemble Capital Management first reported a position in IDXX in Q1 2023 and has held it in 2 quarters since. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Qsemble Capital Management held 1,574 shares of Idexx Laboratories worth $829K as of Q2 2026.
  • Idexx Laboratories was a new Qsemble Capital Management position in Q2 2026.
  • Idexx Laboratories made up 0.11% of Qsemble Capital Management's portfolio in Q2 2026, its #243 holding.
  • Qsemble Capital Management first reported a position in Idexx Laboratories in Q1 2023 and has held it in 2 quarters since.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.